[8] It was found that acarbose reduced the incidence of diabetes mellitus type 2 when compared to placebo, however there was no conclusive evidence that acarbose, when compared to diet and exercise, metformin, placebo, or no intervention, improved all-cause mortality, reduced or increased risk of cardiovascular mortality, serious or non-serious adverse events, non-fatal stroke, congestive heart failure, or non-fatal myocardial infarction
Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function
Contact Austins GLP-1 Weight Loss Specialists Take the first step toward better health and greater confidence right here in Austin
The study found that using the drug increased the risk of vomiting and nausea by more than four times and constipation and diarrhea by more than double